Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 18/20 | 0.61 |
| ▸ | PPARG | P37231 | 17/20 | 0.61 |
| ▸ | PPARD | Q03181 | 17/20 | 0.61 |
| ▸ | NR1H2 | P55055 | 4/20 | 0.61 |
| ▸ | NR1H3 | Q13133 | 4/20 | 0.61 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7473597 | 0.91 | PPARD (0.73) | PPARAPPARGPPARDNR1H2NR1H3 | |
| SCHEMBL5209083 | 0.90 | PPARA (0.60) | PPARAPPARGPPARDNR1H2NR1H3 | |
| SCHEMBL7043351 | 0.90 | PPARD (0.51) | PPARAPPARGPPARDNR1H2NR1H3 | |
| SCHEMBL7041504 | 0.89 | PPARD (0.50) | PPARAPPARGPPARDNR1H2NR1H3 | |
| SCHEMBL5206638 | 0.87 | PPARA (0.65) | PPARAPPARGPPARDNR1H2NR1H3 | |
| SCHEMBL5203759 | 0.85 | PPARD (0.83) | PPARAPPARGPPARDNR1H2NR1H3 | |
| SCHEMBL5205306 | 0.84 | PPARA (0.55) | PPARAPPARGPPARDNR1H2NR1H3 | |
| SCHEMBL7044849 | 0.84 | PPARD (0.54) | PPARAPPARGPPARDNR1H2NR1H3 | |
| SCHEMBL5207961 | 0.83 | PPARA (0.51) | PPARAPPARGPPARDNR1H2NR1H3 | |
| SCHEMBL5209274 | 0.83 | PPARA (0.59) | PPARAPPARGPPARDNR1H2NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1040102-B1 | ARYLTHIAZOLIDINEDIONE DERIVATIVES | MERCK & CO INC (US) | 2007-01-24 | — | — | EP | disclosed |
| EP-1040102-A4 | ARYLTHIAZOLIDINEDIONE DERIVATIVES | MERCK & CO INC (US) | 2002-11-27 | — | — | EP | disclosed |
| EP-1194146-A4 | ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE DERIVATIVES | MERCK & CO INC (US) | 2002-07-31 | — | — | EP | disclosed |
| US-6399640-B1 | ANTIDIABETIC AGENTS; ANTICHOLESTEROL AGENTS | MERCK & CO., INC. | 2002-06-04 | — | — | US | disclosed |
| EP-1194146-A1 | ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE DERIVATIVES | Merck & Co., Inc. (US) | 2002-04-10 | — | — | EP | disclosed |
| US-6200998-B1 | PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONISTS; ANTICHOLESTEROL, ANTIDIABETIC AND ANTIOBESITY AGENTS | MERCK & CO., INC. | 2001-03-13 | — | — | US | disclosed |
| WO-2000078312-A1 | ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE DERIVATIVES | MERCK & CO., INC. (US) | 2000-12-28 | — | — | WO | disclosed |
| EP-1040102-A1 | ARYLTHIAZOLIDINEDIONE DERIVATIVES | Merck & Co., Inc. (US) | 2000-10-04 | — | — | EP | disclosed |
| US-6008237-A | POTENT AGONISTS OF PEROXIDSOME PROLIFERATOR ACTIVATED RECEPTOR; FOR CONTROLLING OR PREVENTING OF DIABETES, HYPERGLYCEMIA, HYPERLIPIDEMIA, HYPERCHOLESTEROLEMIA, ATHEROSCLEROSIS, OBESITY, VASCULAR RESTENOSIS | MERCK & CO., INC. (US) | 1999-12-28 | — | — | US | disclosed |
| WO-1999032465-A1 | ARYLTHIAZOLIDINEDIONE DERIVATIVES | MERCK & CO., INC. (US) | 1999-07-01 | — | — | WO | disclosed |